1,091 results
Page 21 of 55
6-K
gi6sk2a3pbbp5jorm3d
21 Jun 11
Teva and Pfizer Settle Generic Neurontin? Litigation
12:00am
6-K
p6kno3hnsl44c5xx pe4
21 Jun 11
Teva Announces Successful Results of Phase III Study of Its Long-acting G CSF Product (Lipegfilgrastim) In Breast Cancer Patients
12:00am
6-K
lvt zo7p4aq2
14 Jun 11
Teva and Cephalon Receive FTC Request for Additional Information
12:00am
6-K
x5cxgxdkcpaz4nf4
13 Jun 11
Teva Signs $4 Billion Syndicated Credit Facilities
12:00am
6-K
sxowm624khk
2 Jun 11
Teva Announces Launch of Generic Aricept? Tablets In the United States
12:00am
6-K
3vuvcropon6udkd yb
2 Jun 11
Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly
12:00am
6-K
0eog4v9vmn adkfjfv9
31 May 11
Teva Announces Approval of Generic Combivir Tablets: Launch Expected In Fourth Quarter 2011
12:00am
6-K
jmx exm6zh3fg
31 May 11
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-induced Neutropenia In Breast Cancer Patients
12:00am
6-K
8t6nvli 1vsqmjv5
19 May 11
Teva and Oncogenex to Present Data on Custirsen In Prostate Cancer at the 2011 Asco Annual Meeting
12:00am
6-K
aetlsqncirvtc zs
17 May 11
Teva and Curetech Announce Positive Phase II Data from CT-011, an Investigational Antibody In Diffuse Large B Cell Lymphoma
12:00am
6-K
fcft1qr undi7gg9
17 May 11
Teva to Acquire Taiyo
12:00am
6-K
c2il2rfcqerb7zdhec
11 May 11
Current report (foreign)
12:00am
6-K
ozm8kg7n2e9r3jma
11 May 11
Current report (foreign)
12:00am
6-K
EX-99.1
007z tj1si81hic8
11 May 11
Teva Reports First Quarter 2011 Results
12:00am
6-K
dkb4y4i
11 May 11
Current report (foreign)
12:00am
6-K
s4y3a maqlvstz
11 May 11
Current report (foreign)
12:00am
6-K
EX-2.1
i6vd0ely5
3 May 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
2zpld
2 May 11
Teva to Acquire Cephalon In $6.8 Billion Transaction
12:00am
6-K
zcu2at5k aqwxxz9j
25 Apr 11
New Study Demonstrated Significant Reduction In Annualized Relapse Rate and Halting of Disability Progression In MS Patients Switching to Copaxone?
12:00am
6-K
zw6ulgjm3h z5w
12 Apr 11
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
12:00am